Attributes | Values |
---|
rdf:type
| |
rdfs:seeAlso
| |
Description
| - The invention relates to novel ligands of the estrogen receptors α and β of general formula II, which are useful as an active substance of pharmaceuticals, for example pharmaceutical compositions useful for hormone replacement therapy, as well as for the treatment of tumors and inflammatory diseases. The invention also relates to a novel preparation method of these ligands comprising cyclotrimerization of ethynylestradiol with the appropriate diyne in an organic solvent. Further, the invention relates to pharmaceuticals comprising the novel compounds according to the invention.
- The invention relates to novel ligands of the estrogen receptors α and β of general formula II, which are useful as an active substance of pharmaceuticals, for example pharmaceutical compositions useful for hormone replacement therapy, as well as for the treatment of tumors and inflammatory diseases. The invention also relates to a novel preparation method of these ligands comprising cyclotrimerization of ethynylestradiol with the appropriate diyne in an organic solvent. Further, the invention relates to pharmaceuticals comprising the novel compounds according to the invention. (en)
|
Title
| - Ligands of estrogen receptors α and β, method of their preparation, and pharmaceuticals comprising them
- Ligands of estrogen receptors α and β, method of their preparation, and pharmaceuticals comprising them (en)
|
skos:prefLabel
| - Ligands of estrogen receptors α and β, method of their preparation, and pharmaceuticals comprising them
- Ligands of estrogen receptors α and β, method of their preparation, and pharmaceuticals comprising them (en)
|
skos:notation
| - RIV/68378050:_____/12:00388664!RIV13-AV0-68378050
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - Z(AV0Z40550506), Z(AV0Z50520514)
|
http://linked.open...cisloPatentuVzoru
| |
http://linked.open...eleniPatentuVzoru
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/68378050:_____/12:00388664
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - estrogen receptor ligand; hormone therapy; cancer therapy (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...ydaniPatentuVzoru
| |
http://linked.open...atelePatentuVzoru
| - United States Patent and Trademark Office (USPTO)
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...ydaniPatentuVzoru
| |
http://linked.open...iv/tvurceVysledku
| - Bartůněk, Petr
- Kotora, Martin
- Novák, P.
- Sedlák, David
|
http://linked.open...mniOchranaPatentu
| |
http://linked.open...avai/riv/vlastnik
| |
http://linked.open...itiJinymSubjektem
| |
http://linked.open...uzitiPatentuVzoru
| |
http://linked.open...n/vavai/riv/zamer
| |
http://linked.open...stnikPatentuVzoru
| - Ústav molekulární genetiky AV ČR, v. v. i. - Ústav organické chemie a biochemie AV ČR, v. v. i. - Přírodovědecká fakulta UK v Praze
|